Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Side-effects news


From To
South Africa: New safety concerns emerge on latest HIV wonder drug

New safety concerns have emerged about the HIV drug dolutegravir, which the government plans to roll out in April.

18 January 2019
Business Day
Efavirenz in pregnancy is at least as safe as other antiretrovirals

An individual patient data analysis of almost 25,000 pregnancies in women living with HIV has found that the rate of birth defects following exposure to efavirenz was

17 January 2019
Roger Pebody
Sleep Abnormalities Do Not Reverse After Discontinuing Efavirenz

For patients with HIV receiving efavirenz-based therapy, sleep and neuropsychological abnormalities do not readily reverse after discontinuation of treatment, according to results published in HIV Clinical Trials.

14 January 2019
Infectious Disease Advisor
Do integrase inhibitors raise the risk of obesity?

People who take an integrase inhibitor as part of their HIV treatment appear to gain more weight than others after starting treatment and the trend is more

10 January 2019
Keith Alcorn
Efavirenz Likely Safe for Pregnant HIV-Positive Women

The prevalence of birth defects following use of efavirenz (EVF)-based antiretroviral therapy (ART) is not statistically different from non-EFV-based ART during conception or in the first trimester, researchers say.

09 January 2019
Medscape (requires free registration)
Improved liver function, but progressive kidney damage, among children on antiretroviral therapy in Ethiopia

Among HIV-positive children with liver and kidney abnormalities, liver enzyme abnormalities improved while kidney function progressively deteriorated the longer the children were on antiretroviral therapy (ART). With the

02 January 2019
Carole Leach-Lemens
Italian study shows growth in heart and kidney problems in people living with HIV

Reduced kidney function, high blood pressure and cardiovascular disease have each become more common in a large cohort of Italians living with HIV followed since 2004, with

28 December 2018
Keith Alcorn
Top 10 HIV Clinical Developments of 2018

It's the beginning of the end. Not in some apocalyptic way, but rather in how we think about the prevention and management of HIV.

20 December 2018
The Body Pro
Doubt cast on link between tenofovir disoproxil and bone fractures

Treatment with tenofovir disoproxil fumarate (TDF) does not increase the risk of fractures, according to French research published in the online edition of the Journal of Acquired

07 December 2018
Michael Carter
What triggered my heart attack?

Jackie Morton, ex-Chair of the European AIDS Treatment Group, found her severe pain was due to a heart attack. Here she writes a detailed, dispassionate and scientific blog on the possible causes - and remedies.

19 November 2018
← First12345...82Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.